Common Contracts
4 similar Underwriting Agreement contracts by Axsome Therapeutics, Inc., Cleveland Biolabs Inc, Kaival Brands Innovations Group, Inc., Longhai Steel Inc.
4,700,000 Shares of Common Stock and Warrants to Purchase 3,525,000 Shares of Common Stock KAIVAL BRANDS INNOVATIONS GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 4th, 2021 • Kaival Brands Innovations Group, Inc. • Blank checks • New York
Kaival Brands Innovations Group, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, (this “Agreement”), to sell to you, Maxim Group LLC (“Maxim” or the “Underwriter”), an aggregate of 4,700,000 shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and warrants to purchase 3,525,000 shares of Common Stock at an exercise price of $1.90 per share (the “Firm Warrants” and together with the Firm Shares, the “Firm Securities”). In addition, the Company proposes to grant to the Underwriter an option to purchase up to an additional 705,000 shares of Common Stock (the “Option Shares”) and/or up to an additional warrants to purchase an additional 528,750 shares of Common Stock the “Option Warrants” and together with the Option Shares, the “Option Securities”) from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Securities. The Firm Securit
AXSOME THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 2nd, 2015 • Axsome Therapeutics, Inc. • Pharmaceutical preparations • New York
Cleveland BioLabs, Inc. 7,500,000 Shares of Common Stock Warrants to Purchase 3,750,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 22nd, 2012 • Cleveland Biolabs Inc • Services-commercial physical & biological research • New York
The Company has prepared and filed in conformity with the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the published rules and regulations thereunder (the “Rules”) adopted by the Securities and Exchange Commission (the “Commission”) a “shelf” registration statement on Form S-3 (No. 333-167258), which became effective as of June 17, 2010, including a base prospectus (the “Base Prospectus”), in accordance with Rule 415 of the Securities Act and such amendments thereof as may have been required to the date of this Agreement. Copies of such Registration Statement (including all amendments thereof and all documents deemed incorporated by reference therein) and of the related Base Prospectus have heretofore been delivered by the Company or are otherwise available to you.
UNITS LONGHAI STEEL INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 9th, 2010 • Longhai Steel Inc. • Steel works, blast furnaces & rolling & finishing mills • New York
